Kwang Dong Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was KRW 2,364.09 million compared to KRW 2,932.79 million a year ago. Net income was KRW 24,019.07 million compared to KRW 45,369.77 million a year ago.

Basic earnings per share from continuing operations was KRW 585 compared to KRW 1,119 a year ago. Diluted earnings per share from continuing operations was KRW 584 compared to KRW 1,119 a year ago. Basic earnings per share was KRW 585 compared to KRW 1,119 a year ago.

Diluted earnings per share was KRW 584.